Abstract
This chapter covers the topic of the use of medications for the treatment of sex offenders. Alongside giving a historic background, it focuses on the evolvement of the use of “chemical castration” or the use of medications to modify sexual drive. Such medications are currently used either voluntarily or coercively depending on the prevailing legal framework.
Sex offenders quite often are offered medications as a means to increase their autonomy, as an alternative to imprisonment or as a condition for their parole or discharge from hospital settings, with the expectation to improve outcome. The use of such medication for the treatment and management of sex offenders is rarely in isolation and often part of a complex care plan that includes psychotherapeutic and psychological but also social interventions.
In this chapter, we address ethical concerns over the prescription and use of medications to manage sexual arousal and sexual behaviours, especially in prisons and secure hospital settings but also in the community. The focus is on issues around autonomy, capacity, consent, coercion, rationale and medical responsibility.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aagaard L (2014) Chemical castration of Danish sex offenders. J Bioethic Inq 11:117–118. https://doi.org/10.1007/s11673-014-9534-3
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th ed.) (DSM-5). American Psychiatric Association, Arlington, VA
Bain J, Langevin R, Dickey R, Hucker S, Wright P (1988a) Hormones in sexually aggressive men. I. Baseline values for eight sex hormones. II. The ACTH test. Ann Sex Res 1:63–78
Bain J, Langevin R, Hucker S, Dickey R, Wright P, Schonberg C (1988b) Sex hormones in paedophiles. I. Baseline values of six hormones. II. The gonadotropin releasing hormone test. Ann Sex Res 1:443–454
Bancroft J (2005) The endocrinology of sexual arousal. J Endocrinol 10:411–427
Bancroft J (2009) Human sexuality and its problems, 3rd edn. Churchill-Livingstone/Elsevier, Edinburgh
Beauchamp TL (2010) Consent and autonomy. In: Miller F, Wertheimer A (eds) The ethics of consent: theory and practice. Oxford University Press, New York, NY, pp 55–78
Becker JV, Murphy WD (1998) What we know and do not know about assessing and treating sex offenders. Psychol Publ Pol Law 4(1/2):116–137
Berlin FS (1997) “Chemical Castration” for sex offenders. N Engl J Med 336(14):1030
Blasko BL (2016) Overview of sexual offender typologies, recidivism, and treatment. Chapter 2. In: Jeglic EL, Calkins C (eds) Sexual violence. Springer International Publishing, Cham. https://doi.org/10.1007/978-3-319-44504-5_2
Clark VA, Duwe G (2015) What predicts where sex offenders live? An examination of census track data in Minnesota. Crim Justice Policy Rev 28:488–510. https://doi.org/10.1177/0887403415594200
Cohen-Kettenis PT, Gooren LJG (1993) The influence of hormone treatment on psychological functioning of transsexuals. J Psychol Hum Sex 5(4):55–67. https://doi.org/10.1300/J056v05n04_04
Cooper AJ (1986) Progestogens in the treatment of male sex offenders: a review. Can J Psychiatry 31(1):73–79
Cortoni F, Sandler JC, Freeman NJ, Kozlowski K (2015) Factors related to sexual recidivism among women. In: Breaking New Ground: Understanding and Preventing Sexual Abuse 2015 ATSA Conference. Conference abstract. Accessed on 18 Jul 2018 from http://www.atsa.com/pdfs/Conf2015/F-18.pdf
Craig L, Hutchinson RB (2005) Sexual offenders with learning disabilities: risk, recidivism and treatment. J Sex Aggress 11(3):289–304
Craig LA, Browne KD, Stringer I (2003) Treatment and sexual offence recidivism. Trauma Violence Abuse 4:70–89
Daley M (2008) A flawed solution to the sex offender situation in the united states: the legality of chemical castration for sex offenders. Indiana Health Law Rev 5:87. Accessed on 6 May 2018 from https://mckinneylaw.iu.edu/ihlr/pdf/vol5p87.pdf
Douglas T, Bonte P, Focquaert F, Devolder K, Sterckx S (2013) Coercion, incarceration, and chemical castration: an argument from autonomy. Bioethic Enq 10:393–405. https://doi.org/10.1007/s11673-013-9465-4
Fanniff AM, Becker JV (2006) Specialised assessment and treatment of adolescent sex offenders. Aggress Violent Behav 11:265–282
Fazel S, Hope T, O’Donnell I, Jacoby R (2002) Psychiatric, demographic and personality characteristics of elderly sex offenders. Psychol Med 32(2):219–226
Federal Bureau of Investigation (2006) Crime in the United States, 2005: uniform crime reports. U.S. Department of Justice, Federal Bureau of Investigation, Washington, DC
Federal Bureau of Investigation (2016) Crime in the United States, 2016: uniform crime reports. U.S. Department of Justice, Federal Bureau of Investigation, Washington, DC. Available from https://ucr.fbi.gov/crime-in-the-u.s/2016/resource-pages/downloads
Fedoroff JP, Fedoroff IC (1992) Buspirone and paraphilic sexual behaviour. J Offender Rehabil 18:89–108
Friendship C, Mann RE, Beech AR (2003) Evaluation of a national prison-based treatment program for sexual offenders in England and Wales. J Interpers Violence 18:744–759
Furby L, Weinrott MR, Blackshaw L (1989) Sex offender recidivism: a review. Psychol Bull 105:3–30
Gallagher CA, Wilson DB, Hirschfield P, Coggeshall MB, MacKenzie DL (1999) Quantitative review of the effects of sex offender treatment on sexual reoffending. Correct Manag Quart 3:19–29
Garcia FD, Garcia HD, Assumpção AFA, Thibaut F (2013) Pharmacologic treatment of sex offenders with paraphilic disorder. Curr Psychiatry Rep 15:356. https://doi.org/10.1007/s11920-013-0356-5
Genetics Generation (n.d.) Introduction to Eugenics. Accessed on 5 Jun 2018 from http://knowgenetics.org/history-of-eugenics/
Giguere R, Bumby K (2007) Female sex offenders. A project of the Office of Justice Programs. U.S. Department of Justice, Center for Sex Offender Management, Washington, DC. Accessed on 19 Jul 2018 from http://www.csom.org/pubs/female_sex_offenders_brief.pdf
Grossman LS, Martis B, Fichtner CG (1999) Are sex offenders treatable? A research overview. Psychiatr Serv 50(3):349–361
Grubin D (2018) The pharmacological treatment of sex offenders. Chapter 27. In: Beech AR, Carter AJ, Mann RE, Rotshtein P (eds) The Wiley Blackwell handbook of forensic neuroscience, 1st edn. Wiley, New York, NY. https://doi.org/10.1002/9781118650868.ch27
Grubin D, Beech A (2010) Chemical castration of sex offenders. BMJ 340:c74
Hall GCN (1995) Sexual offender recidivism revisited. A meta-analysis of recent treatment studies. J Consult Clin Psychol 63:802–809
Hanson RK, Bussiere MT (1998) Predicting relapse: a meta-analysis of sexual offender recidivism studies. J Consult Clin Psychol 66:348–362
Hanson RK, Morton-Bourgon KE (2005) The characteristics of persistent sexual offenders: a meta-analysis of recidivism studies. J Consult Clin Psychol 73(6):1154–1163. https://doi.org/10.1037/0022-006X.73.6.1154
Hanson RK, Gordon A, Harris AJR, Marques JK, Murphy W, Quinsey VL, Seto MC (2002) First report of the collaborative outcome data project on the effectiveness of psychological treatment for sex offenders. Sex Abuse 14(2):169–194. https://doi.org/10.1023/A:1014624315814
Harrison K (2007) The high-risk sex offender strategy in England and Wales: is chemical castration an option? Howard J 46(1):16–31. ISSN 0265-5527
Heim N (1981) Sexual behaviour of castrated sex offenders. Arch Sex Behav 10(1):11–19
Henggeler SW (2012) Multisystemic therapy: clinical foundations and research outcomes. Psychosoc Interv 21:181–193
Hill A, Briken P, Kraus C, Strohm K, Berner W (2003) Differential pharmacological treatment of paraphilias and sex offenders. Int J Offender Ther Comp Criminol 47(4):407–421
Hunt J, Mills AM (2012) The unfair criminalization of gay and transgender youth. An overview of the experiences of LGBT youth in the Juvenile Justice System. Center for American Progress, Washington, DC, pp 1–12. Accessed on 12 Jul 2018 from https://www.ncjrs.gov/App/Publications/abtract.aspx?ID=267708
Jordan K, Fromberger P, Stolpmann G, Müller JL (2011) The role of testosterone in sexuality and paraphilia - a neurobiological approach. Part I: Testosterone and sexuality. J Sex Med 8:2993–3007
Kafka MP (1994) Sertraline pharmacotherapy for paraphilias and paraphilia related disorders: an open trial. Ann Clin Psychiatry 6:109–125
Kafka MP, Prentky R (1992) Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men. J Clin Psychiatry 53:351–358
Kalichman SC, Rompa D (1995) Sexual sensation seeking and sexual compulsivity scales: reliability, validity, and predicting HIV risk behavior. J Pers Assess 65:586–601
Kalichman SC, Johnson JR, Adair V, Rompa D, Multhauf K, Kelly JA (1994) Sexual sensation seeking: scale and development and predicting AIDS-risk behavior among homosexually active men. J Pers Assess 62:385–397
Kim B, Benekos PJ, Merlo AV (2016) Sex offender recidivism revisited. Review of recent meta-analyses on the effects of sex offender treatment. Trauma Violence Abuse 17(1):105–117. https://doi.org/10.1177/1524838014566719
Kingsberg SA, Clayton AH, Pfaus JG (2015) The female sexual response: current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of hypoactive sexual desire disorder. CNS Drugs 29:915–933. https://doi.org/10.1007/s40263-015-0288-1
Kingston DA, Seto MC, Ahmed AG, Fedoroff P, Firestone P, Bradford JM (2012) The role of central and peripheral hormones in sexual and violent recidivism in sex offenders. J Am Acad Psych Law 40:476–485
Knack NM, Murphy L, Ranger R, Meston C, Fedoroff JP (2015) Assessment of female sexual arousal in forensic populations. Curr Psychiatry Rep 17(4):557. https://doi.org/10.1007/s11920-015-0557-1
Koo KC, Ahn JH, Hong SJ, Lee JW, Chung BH (2014) Effects of chemical castration on sex offenders in relation to the kinetics of serum testosterone recovery: implications for dosing schedule. J Sex Med 11(5):1316–1324. https://doi.org/10.1111/ism.12492
Kruesi MJ, Fine MB, Valladates L, Phillips RA Jr, Rapoport JL (1992) Paraphilias: a double-blind crossover comparison of clomipramine versus desipramine. Arch Sex Behav 21:587–593
Lai MQY (2014) The ethics of the use of androgen deprivation therapy (ADT) for child sex offenders. Thesis for the degree of Master of Research. Department of Philosophy, Macquarie University. Accessed on 17 Jul 2018 from https://www.researchonline.mq.edu.au/vital/access/services/Download/mq:44385/SOURCE1
Le Marie L (1956) Danish experiences regarding the castration of sexual offenders. J Crim Law Criminol 47(3):294–310. Article 3
Lee JY, Cho KS (2013) Chemical castration for sexual offenders: physician’s views. J Korean Med Sci 28:171–172
Letourneau EJ, Henggeler SW, Borduin CM, Schewe PA, McCart MR, Chapman JE, Saldana L (2009) Multisystemic therapy for juvenile sexual offenders: 1-year results from a randomised effectiveness trial. J Fam Psychol 23:89–102
Levin RJ, Both S, Georgiadis J, Kukkonen T, Park K, Yang CC (2016) The physiology of female sexual function and the pathophysiology of female sexual dysfunction (Committee 13A). J Sex Med 13:733–759
Lösel F, Schmucker M (2005) The effectiveness of treatment for sexual offenders: a comprehensive meta-analysis. J Exp Criminol 1(1):117–146
Mann RE, Hanson RK, Thornton D (2010) Assessing risk for sexual recidivism: some proposals on the nature of psychologically meaningful risk factors. Sex Abuse 22(2):191–217
McAlinden AM (2012) The governance of sexual offending across Europe: penal policies, political economies and the institutionalisation of risk. Punishment Soc 14(2):166–192
McBrien J, Hodgetts A, Gregory J (2003) Offending and risky behaviour in community services for people with intellectual disabilities in one local authority. J Forensic Psychiatry Psychol 14(2):280–297. https://doi.org/10.1080/1478994031000084828
McElroy S, Soutullo C, Taylor P, Nelson E, Beckman D, Brusman L, Ombaba J, Strakowski S, Keck P (1999) Psychiatric features of 36 men convicted of sexual offenses. J Clin Psychiatry 60:414–420
McMillan J (2013) The kindest cut? Surgical castration, sex offenders and coercive offers. J Med Ethics 40(9):583–590. https://doi.org/10.1136/medethics-2012-101030
Meyer WJ III, Cole CM (2008) Physical and chemical castration of sex offenders. J Offender Rehabil 25(3-4):1–18. https://doi.org/10.1300/J076v25n03_01
Miller RD (1998) Forced administration of sex-drive reducing medications to sex-offenders: treatment or punishment. Psychol Publ Pol Law 4(1-2):175–199
Norrgard K (2008) Human testing, the eugenics movement, and IRBs. Nat Educ 1(1):170. Accessed on 5 Jun 2018 from https://www.nature.com/scitable/topicpage/human-testing-the-eugenics-movement-and-irbs-724
Oliver BE (2007) Preventing female-perpetrated sexual abuse. Trauma Violence Abuse 8(1):19–32
Petrunik MG (2002) Managing unacceptable risk: sex offenders, community response, and social policy in the United States and Canada. Int J Offender Ther Comp Criminol 46(4):483–511
Quinsey VL, Harris GT, Rice ME, Lalumiere ML (1993) Assessing treatment efficacy in outcome studies of sex offenders. J Interpers Violence 8(4):512–523
Ramsey-Klawsnik H (1990) Sexual abuse by female perpetrators: impact on children. Paper presented on the National Symposium on Child Victimisation, Atlanta, GA
Rösler A, Witztum E (2000) Pharmacotherapy of paraphilias in the next millennium. Behav Sci Law 18(1):43–56
Routh D, Abess G, Makin D, Stohr MK, Hemmens C, Yoo J (2017) Transgender inmates in prisons: a review of applicable statutes and policies. Int J Offender Ther Comp Criminol 61(6):645–666
Scott CL, Holmberg T (2003) Castration of sex offenders: prisoners’ rights versus public safety. J Acad Psych Law 31(4):502–509
Sedkaoui H, Mullet E (2016) Mapping French people’s views on chemical castration of child and adolescent sex offenders. Univ Psychol 15(3):1. ISSN 1657-9267
Sexton L, Jenness V, Sumner JM (2010) Where the margins meet: a demographic assessment of transgender inmates in men’s prisons. Justice Quart 27(6):835–866. https://doi.org/10.1080/07418820903419010
Skett S, Winder B, Kaul A, Hocken K, Grubin D, Norman C, Faulkner J, Elliot H, Lievesley R (2016) Medication to manage sexual arousal. In: Offender personality disorder pathway. NHS England, National Offender Management Service, London. Available from https://www.researchgate.net/profile/Belinda_Winder/publication/322505234_The_use_of_medication_to_manage_sexual_arousal_for_individuals_in_secure_settings/links/5a6343590f7e9b6b8fd7647d/The-use-of-medication-to-manage-sexual-arousal-for-individuals-in-secure-settings.pdf
Stein DJ, Hollander E, Anthony DT, Schneier FR, Fallon BA, Liebowitz MR, Klein DF (1992) Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias. J Clin Psychiatry 53:267–271
Strickland SM (2008) Female sex offenders: exploring issues of personality, trauma, and cognitive distortions. J Interpers Violence 23(4):474–489
Snyder H, Mulako-Wantota J (2013) Bureau of Justice Statistics. Arrest Data Analysis Tool. Available online at www.bjs.gov/index.cfm?ty=datool&surl=/arrests/index.cfm
Tarzwell S (2006) The gender lines are marked with razor wire: addressing state prison policies and practices for the management of transgender prisoners. Columbia Hum Rights Law Rev 38:167–220
Thibaut F, Bradford JMW, Briken P, DeLaBarra F, Häßler F, Cosyns P, on behalf of the WFSBP Task Force on Sexual Disorders (2016) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the treatment of adolescent sexual offenders with paraphilic disorders. World J Biol Psychiatry 17(1):2–38. https://doi.org/10.3109/15622975.2015.1085598
Thompson D, Brown H (1997) Men with intellectual disabilities who sexually abuse: a review of the literature. J Appl Res Intellect Disabil 10(2):140–158
Vandiver DM (2006) Female sex offenders: a comparison of solo offenders and co-offenders. Violence Vict 21(3):339–354
Vandiver DM, Kercher G (2004) Offender and victim characteristics of registered female sex offenders in Texas: a proposed typology of female sexual offenders. Sex Abuse 16:121–137
Verheul R, Andrea H, Berghout CC, Dolan C, Busschbach JJV, Van der Kroft PJA, Bateman AW, Fonagy P (2008) Severity indices of personality problems (SIPP–118): development, factor structure, reliability, and validity. Psychol Assess 20:23–34. https://doi.org/10.1037/1040-3590.20.1.23
Walker DF, McGovern SK, Poey EL, Otis KE (2004) Treatment effectiveness for male adolescent sexual offenders: a meta-analysis and review. J Child Sex Abus 13(3-4):281–293
Weinberger LE, Sreenivasan S, Garrick T, Osran H (2005) The impact of surgical castration on sexual recidivism risk among sexually violent predatory offenders. J Am Acad Psychiatry Law 33:16–36
Wong JS, Gravel J (2018) Do sex offenders have higher levels of testosterone? Results from a meta-analysis. Sex Abuse 30(2):147–168
World Health Organization (1992) The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva
Worling JR, Långström N (2006) Risk of sexual recidivism in adolescents who offend sexually, correlates and assessment. In: Barbaree HE, Marshall WL (eds) The juvenile sex offender, 2nd edn. The Guilford Press, New York, NY
Yaki M (1985) Medical treatment for imprisoned paraphiliacs: implementing a modified standard for deliberate indifference. Yale Law Pol Rev 4(1):251–282. Article 12
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Igoumenou, A. (2020). The Use of Medication for the Treatment of Sex Offenders: Ethical Issues and Controversies. In: Igoumenou, A. (eds) Ethical Issues in Clinical Forensic Psychiatry . Springer, Cham. https://doi.org/10.1007/978-3-030-37301-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-37301-6_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-37300-9
Online ISBN: 978-3-030-37301-6
eBook Packages: MedicineMedicine (R0)